Diagnostics News and Research RSS Feed - Diagnostics News and Research

ACCA Clinical Decision-Making Toolkit mobile app helps make quick and correct decision

ACCA Clinical Decision-Making Toolkit mobile app helps make quick and correct decision

The ACCA Clinical Decision-Making Toolkit mobile app is now available on the App Store and Google Play. When dealing with acute cardiovascular diseases, a few seconds can make the difference and instant access to the best recommendations can save lives. [More]
Freiburg biochemists discover new mechanisms of brain disease

Freiburg biochemists discover new mechanisms of brain disease

The failing in the work of nerve cells: An international team of researchers led by Prof. Dr. Chris Meisinger from the Institute of Biochemistry and Molecular Biology of the University of Freiburg has discovered how Alzheimer's disease damages mitochondria, the powerhouses of the cell. [More]
Pixcelldata, eX-Path announce major new deal in advance of ECP 2014

Pixcelldata, eX-Path announce major new deal in advance of ECP 2014

Pixcelldata, the innovative Irish developer of digital pathology management and collaboration software has announced a major new deal with Dutch based eX-Path, global providers of tele-pathology services, founded by renowned pathology expert, Dr. Marius Nap. [More]
CTC clusters cause metastasis

CTC clusters cause metastasis

Circulating tumor cell (CTC) clusters - clumps of from 2 to 50 tumor cells that break off a primary tumor and are carried through the bloodstream - appear to be much more likely to cause metastasis than are single CTCs, according to a study from investigators at the Massachusetts General Hospital Cancer Center. [More]
New treatment fights respiratory syncytial virus

New treatment fights respiratory syncytial virus

The New England Journal of Medicine published research results on Aug. 21 from a clinical trial of a drug shown to safely reduce the viral load and clinical illness of healthy adult volunteers intranasally infected with respiratory syncytial virus (RSV). [More]
TGen to lead first-in-patient clinical trial studies to test novel drugs for glioblastoma

TGen to lead first-in-patient clinical trial studies to test novel drugs for glioblastoma

SIn 2012, The Ben & Catherine Ivy Foundation awarded $10 million in grants for two groundbreaking brain cancer research projects at the Translational Genomics Research Institute. One of those projects has officially received the final regulatory approval from University of California, San Francisco, which means patient enrollment for the trial can begin. [More]
Pharmatech begins enrollment for AccessPPM program

Pharmatech begins enrollment for AccessPPM program

Pharmatech initiated enrollment for its AccessPPM program after a two-year investment into this game-changing method for matching cancer patients to cancer clinical trials. [More]
Report on Co-development Terms & Agreements in Pharma, Biotech and Diagnostics

Report on Co-development Terms & Agreements in Pharma, Biotech and Diagnostics

The Co-development Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading life science companies. [More]
Meridian Health joins "The Baton Pass" to spread message of hope

Meridian Health joins "The Baton Pass" to spread message of hope

Meridian Health, a leading health care system in New Jersey, joined a national movement called "The Baton Pass™" to help raise funds for innovative cancer research and spread a message of hope. [More]
Spring Bioscience launches PD-L1 (SP142) rabbit monoclonal immunohistochemistry antibody1

Spring Bioscience launches PD-L1 (SP142) rabbit monoclonal immunohistochemistry antibody1

Spring Bioscience (Spring), a member of the Roche Group, today announced the launch of its PD-L1 (SP142) rabbit monoclonal immunohistochemistry (IHC) antibody. [More]
Cilag GmbH International acquires biopharmaceutical company, Covagen AG

Cilag GmbH International acquires biopharmaceutical company, Covagen AG

Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired Covagen AG, a privately-held, biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb® technology platform. [More]
ESAOTE launches MyLab™Six at European Society of Cardiology 2014

ESAOTE launches MyLab™Six at European Society of Cardiology 2014

Esaote, one of the world’s leading manufacturers of medical diagnostic systems, is launching MyLab™Six, a fast, accurate and highly flexible enhanced ultrasound system at ESC (European Society of Cardiology, Barcelona, 30th August - 3rd September). Configured for an extensive range of applications, MyLab™Six delivers a premium quality, yet affordable, solution for shared ultrasound services across any busy clinical setting. [More]
ESAOTE launches MyLab™Gamma  at European Society of Cardiology 2014

ESAOTE launches MyLab™Gamma at European Society of Cardiology 2014

Esaote, one of the world’s leading manufacturers of medical diagnostic systems, is launching MyLab™Gamma, a best in class, highly-portable “green” ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, 30th August - 3rd September). Based on Esaote’s productivity-oriented operating platform, the super-light, feature packed portable system sets ultrasound free to be used in any environment - at a moment’s notice. [More]
SeraCare Life Sciences announces launch of new ACCURUN 501 C. difficile Control

SeraCare Life Sciences announces launch of new ACCURUN 501 C. difficile Control

SeraCare Life Sciences, a provider of high-quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, today announced the launch of its new ACCURUN 501 C. difficile Control – the company's first molecular control product targeting hospital acquired infections. [More]

New report forecasts growth of Global Operating Room Equipment market

Research and Markets has announced the addition of the "Global Operating Room Equipment Market 2014-2018" report to their offering. [More]
ESMO announces names of outstanding individuals receiving annual awards

ESMO announces names of outstanding individuals receiving annual awards

The European Society for Medical Oncology, the leading pan-European organisation representing medical oncologists, announced the names of outstanding individuals receiving the Society's esteemed annual awards, to be presented during the ESMO 2014 Congress, on 26 September, in Madrid. [More]
Novel "man and machine" decision support system for diagnosing malaria infection

Novel "man and machine" decision support system for diagnosing malaria infection

A Finnish-Swedish research group at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki, and Karolinska institutet, Stockholm, has developed a novel "man and machine" decision support system for diagnosing malaria infection. [More]
Ohio State, Nationwide Children's Hospital partner with ENTvantage for diagnosing bacterial sinusitis

Ohio State, Nationwide Children's Hospital partner with ENTvantage for diagnosing bacterial sinusitis

The Ohio State University, through the Ohio State Innovation Foundation, and Nationwide Children's Hospital announced the signing of an exclusive, world-wide agreement with ENTvantage Diagnostics Inc. licensing a technology for rapid diagnosing of bacterial sinusitis. [More]
Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine

Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine

The most common form of diabetes is sometimes referred to as metabolic diabetes, which is the diabetes most people are very familiar with, type 2 diabetes. This form of diabetes is most prevalent in people that are overweight or obese. Historically, it has been confined to adults or older patients but it has been on the rise as the global obesity problem has continued to worsen. [More]
Trovagene announces results from clinical studies on urine-based diagnostic test for detection of HPV

Trovagene announces results from clinical studies on urine-based diagnostic test for detection of HPV

Trovagene, Inc., a developer of cell-free molecular diagnostics, announced today that results from two clinical studies will be presented at the 29th International Papillomavirus conference for the Company's urine-based diagnostic test for the detection of high risk strains of Human Papillomavirus. [More]